Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
entresto
novartis europharm limited - sacubitril, valsartan - hjartabilun - ace ii hemla, önnur sturtu, umboðsmenn starfa á renín-ace kerfi - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
neparvis
novartis europharm limited - sacubitril, valsartan - hjartabilun - lyf sem hafa áhrif á renín-angíótensín kerfið - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
fragmin stungulyf, lausn í áfylltri sprautu með nálarvörn 12.500 and-xa a.e.
pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu með nálarvörn - 12.500 and-xa a.e.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
fragmin stungulyf, lausn í áfylltri sprautu með nálarvörn 7.500 and-xa a.e.
pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu með nálarvörn - 7.500 and-xa a.e.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
fragmin stungulyf, lausn í áfylltri sprautu 15.000 anti-xa iu
pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu - 15.000 anti-xa iu
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
fragmin stungulyf, lausn í áfylltri sprautu 5.000 anti-xa iu
pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu - 5.000 anti-xa iu
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
fragmin stungulyf, lausn 25.000 and-xa a.e./ml
pfizer aps - dalteparinum natricum inn - stungulyf, lausn - 25.000 and-xa a.e./ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
fragmin stungulyf, lausn í áfylltri sprautu 2.500 anti-xa iu
pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu - 2.500 anti-xa iu
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
fragmin stungulyf, lausn 10.000 anti-xa iu/ml
pfizer aps - dalteparinum natricum inn - stungulyf, lausn - 10.000 anti-xa iu/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
fragmin stungulyf, lausn í áfylltri sprautu 7.500 anti-xa iu
pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu - 7.500 anti-xa iu